vaccine - Page 3

Après l’annonce du laboratoire Pfizer affirmant détenir un vaccin efficace à 90 %, le débat sur la vaccination s’ouvre et promet d’être houleux. Nous versons ici une première tribune signée par la britannique Melinda Mills, professeur à l’Université d’Oxford, et auteur du rapport de l’Académie britannique et de la Royal

Dès son annonce hier 9 novembre, le vaccin de l’américain Pfizer associé à l’allemand BioNTech, « efficace à 90 % », a fait la une de tous les médias et provoqué une flambée des Bourses occidentales. Il est évident qu’un vaccin éliminerait une grande partie de nos soucis, le monde respirerait et

Tandis que les laboratoires Pfizer annoncent que leur « candidat » vaccin anti Covid-19 est efficace à 90%, faisant s’envoler toutes les Bourses, que Sanofi vient de démarrer les essais sur l’homme de son potentiel vaccin, les Français se montrent bien plus réticents que la moyenne de la population mondiale à se

We know more or less well how the Covid-19 outbreak started: probably because of bats, near Wuhan in China. What no one knows yet is how the pandemic will end. This coronavirus is unprecedented in the combination of its easy transmissibility, a series of

Sanofi, by announcing that the United States would be the first to distribute a potential vaccine against Covid-19, provoked anger and indignation. COVID-19 has no nation or ethnicity. If the pandemic is not monitored in one country, it will accelerate beyond the borders of that country.

There is every indication that the coronavirus that is shaking the world could establish itself as an endemic virus, present for a long time, with seasonal peaks in virulence. In this hypothesis, medical experts fear that there may not be enough vaccine for everyone. According to the scientists, it would be necessary to vaccinate

Epidemiological studies suggest that the world's oldest vaccine, the BCG used against tuberculosis, may reduce the risk of coronavirus infection as well as the risk of severe forms of Covid-19 disease. Professor Camille Locht, director of INSERM research at the Pasteur Institute in Lille, France, is the author of this study.

The United States has taken the option of having hundreds of millions of doses of vaccine manufactured, even before clinical trials have begun. They want to be ready for the market before others are. A risk in the form of a poker strike.

British American Tobacco, the manufacturer of cigarette brands such as Lucky Strike, Dunhill, Rothmans and Benson & Hedges, said a potential vaccine against coronavirus was being developed from tobacco plants. According to the firm, tobacco plants cannot, by their nature, be used to produce a vaccine,

Scientists from one of the world's leading epidemiology centres, the American Johns Hopkins University, have just published an article that opens up unexpected prospects in these gloomy epidemic times. They explain how viral antibodies, contained in the blood serum of patients cured of coronavirus, could then be used to treat the disease.

The coronavirus pandemic that has hit the world requires a war effort. On the front lines, biotech labs are working tirelessly to discover new weapons to treat and test affected patients and to contain the epidemic in the long term. European laboratories, which are among

Cela fait vingt-cinq ans que l’on nous parle d’un vaccin contre le Sida. Dès 1984 les services de santé publique parlent d’un vaccin imminent. Force est de constater que, malgré l’acharnement d’équipes de scientifiques partout dans le monde, le vaccin se fait encore attendre.  Où en sommes-nous, à quel horizon

It is a highly contagious disease that was thought to have been eradicated by vaccination. Before the vaccine, up to two and a half million people died each year from measles. Thanks to vaccination campaigns, the disease should have disappeared completely. Today, however, there is a health alert all over the world.

Let us not celebrate victory too soon and let us not raise undue hopes. The long-awaited cancer vaccine is not going to be on the pharmacy shelves tomorrow morning. But researchers at Stanford University have completed some very promising experiments that they have just published. Their

Une étude à un stade encore préliminaire sur un vaccin contre le VIH a donné des résultats “encourageants”, une note d’optimisme alors que la recherche a jusqu’ici échoué à mettre au point un vaccin efficace pour protéger de ce virus.   Testé chez 393 volontaires dans cinq pays (Etats-Unis, Rwanda,

Qui aurait cru que la France puisse être le pays le plus « sceptique » de la planète face aux vaccins ? Et ce qui étonne encore plus derrière les chiffres dévoilés ces derniers jours, s’ils s’avèrent exacts, c’est que personne ne semble comprendre pourquoi la France se démarque à